Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways.
Sordella R; Bell DW; Haber DA; Settleman J; Science (New York, N.Y.), 2004, vol. 305, issue 5687, p 1163, ISSN 10959203. ISBN 10959203.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef